Cargando…
Neonatal rebound hyperkalemia associated with ritodrine alone: a case report
BACKGROUND: Betamimetics have been used for tocolysis extensively in the past, and one of them, ritodrine is widely used in Japan. Various adverse events have been reported for this agent, including newborn hypoglycemia and hypokalemia, as well as maternal hypokalemia and rebound hyperkalemia; howev...
Autores principales: | Osumi, Keita, Suga, Kenichi, Suzue, Masashi, Nakagawa, Ryuji, Kagami, Shoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405715/ https://www.ncbi.nlm.nih.gov/pubmed/34465290 http://dx.doi.org/10.1186/s12887-021-02840-8 |
Ejemplares similares
-
Rebound hyperkalemia after cessation of ritodrine in a parturient undergoing cesarean section
por: Takekawa, Daiki, et al.
Publicado: (2017) -
Synergic interaction between ritodrine and magnesium sulfate on the occurrence of critical neonatal hyperkalemia: A Japanese nationwide retrospective cohort study
por: Yada, Yukari, et al.
Publicado: (2020) -
Ritodrine-Induced Agranulocytosis: A Case Report and Literature Review
por: Daimon, Atsushi, et al.
Publicado: (2020) -
Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
por: Liu, Wen-Yu, et al.
Publicado: (2022) -
Ritodrine-Induced Hypokalemia
por: Sohn, Il-Suk, et al.
Publicado: (2009)